CVSA Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Sustainable Profitability & MarginsConsistently strong gross and operating margins indicate durable pricing power and efficient delivery in Covista's education model. High EBITDA margins support reinvestment, debt servicing and shareholder actions, and provide a buffer against cyclical revenue swings over the next several quarters.
Enrollment Momentum & ScaleSustained enrollment growth across programs (Walden, Chamberlain, Med/Vet) strengthens recurring revenue and expands scale benefits. A larger student base boosts lifetime revenue, supports campus expansion and credential rollouts, and underpins long‑term margin stability and competitive positioning.
Improving Balance Sheet & Cash GenerationStronger FCF and lower net leverage enhance financial flexibility for strategic investments, buybacks and debt servicing. The refinancing reduces interest cost and extends maturities, materially improving covenants and optionality and lowering refinancing risk over the medium term.
Bears Say
Free Cash Flow VolatilityIntermittent and declining FCF growth undermines the predictability of internal funding for capex, campus builds and buybacks. Historic swings (including weak/negative FCF in 2022) raise execution and liquidity risk if enrollment or margins soften, necessitating external financing options.
Meaningful Absolute Debt LoadAlthough leverage has improved, a sizable absolute debt stock increases sensitivity to slower cash generation or rising rates. Debt service and covenant maintenance could constrain capital allocation and amplify downside in a downturn, limiting nimbleness for M&A or larger program investments.
Investment & Execution HeadwindsA planned ramp in strategic spending and capex to fund campuses and programs will weigh near-term margins and cash flow. Modest recovery at Chamberlain and weaker RN‑to‑BSN demand create execution risk that could delay payback on those investments and pressure profitability through the next several quarters.
Covista News
CVSA FAQ
What was Covista Inc.’s price range in the past 12 months?
Currently, no data Available
What is Covista Inc.’s market cap?
Covista Inc.’s market cap is CHF3.44B.
When is Covista Inc.’s upcoming earnings report date?
Covista Inc.’s upcoming earnings report date is Aug 06, 2026 which is today.
How were Covista Inc.’s earnings last quarter?
Currently, no data Available
Is Covista Inc. overvalued?
According to Wall Street analysts Covista Inc.’s price is currently Undervalued.
Does Covista Inc. pay dividends?
Covista Inc. does not currently pay dividends.
What is Covista Inc.’s EPS estimate?
Covista Inc.’s EPS estimate is 1.53.
How many shares outstanding does Covista Inc. have?
Currently, no data Available
What happened to Covista Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Covista Inc.?
Currently, no hedge funds are holding shares in CH:CVSA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Covista Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
CHF139.50 (― Downside)
CHF139.50 (― Downside)
Blogger Sentiment
Bullish
CH:CVSA Sentiment 83%
Sector Average ―
Sector Average ―
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.34%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-1.88%
Trailing 12-Months
Company Description
Covista Inc.
Adtalem Global Education, Inc. is an enterprise dedicated to providing higher education. The company organizes its operations into three primary divisions: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment delivers various degree and non-degree offerings within the nursing and broader health professions higher education sector. Through its Walden segment, the company offers extensive online learning options, including certificates, bachelor's, master's, and doctoral degrees in a wide range of subjects such as nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. The Medical and Veterinary division provides both degree-granting and non-degree curricula tailored for post-secondary education in medicine and veterinary sciences. Dennis J. Keller and Ronald L. Taylor established the company in 1973, and its corporate headquarters are situated in Chicago, Illinois.
CVSA Company Deck
CVSA Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: enrollment growth across institutions, improved margins (when adjusting for a one-week timing shift), raised revenue and EPS guidance, robust free cash flow, balance sheet improvement, share repurchases, campus expansion plans, and technology/AI initiatives. Near-term headwinds include an $18M timing impact at Walden that masked stronger underlying results, modest absolute enrollment improvement at Chamberlain this quarter (0.5%), continued investment-driven CapEx and strategic spending, and an expected higher effective tax rate. Overall, the positives (organic growth, margin expansion excluding timing, raised guidance, cash generation, and clear remediation at Chamberlain) outweigh the transitory and execution-related challenges noted.View all CH:CVSA earnings summariesCVSA Stock 12 Month Forecast
Average Price Target
$139.50
Perdoceo Education
―
Grand Canyon Education
―
Strategic Education
―
Graham Holdings
―
Laureate Education
―